FDAnews
www.fdanews.com/articles/205223-novavax-pursues-who-emergency-use-listing-of-covid-19-vaccine

Novavax Pursues WHO Emergency Use Listing of COVID-19 Vaccine

November 8, 2021

Novavax has finished submitting data to the World Health Organization (WHO) to support an emergency use listing of its COVID-19 vaccine, NVX-CoV2373.

A listing would allow the shot’s inclusion in the WHO-backed COVAX vaccine-sharing program.

The company also recently filed for authorization with the UK’s Medicines and Healthcare products Regulatory Agency, Health Canada and the European Medicines Agency, among others, and plans to pursue an FDA Emergency Use Authorization by year’s end.

Indonesia, which has a population of more than 273 million, has already granted emergency use approval to the vaccine, to be manufactured by the Serum Institute of India.

View today's stories